$IRMD Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.55 up 17.02% YoY
• Reported revenue of $24.2M up 14.15% YoY
• Iradimed expects Q4 2026 revenue of $25M to $26.5M and GAAP diluted EPS of $0.53 to $0.57; FY2026 revenue of $91.6M to $93.1M and GAAP diluted EPS of $1.90 to $1.94.